Jonathan Allan, GENERAL COUNSEL & Corporate Secretary at Stoke Therapeutics, Inc. (STOK), sold 17,198 shares at $15.04 ($259K) on 2024-05-20, disclosed to the SEC on 2024-05-22.
Scheduled sale ($259k) by GENERAL COUNSEL & Corporate Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.04 | 8,599 | $129K | 50.0% |
| 2 | $15.04 | 8,599 | $129K | 50.0% |
| Total | $15.04 avg | 17,198 | $259K | 100% |
| Filing → |
| STOK | SELL | 2026-06-18 | $44K | — | Filing → |
| STOK | SELL | 2026-03-24 | $626K | — | Filing → |
| STOK | SELL | 2026-03-19 | $569K | — | Filing → |